Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20015299HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20067886HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20015177HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20026584HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20016513HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS20030798HPVENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS44020094HTLV-1ENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TVIS44022969HTLV-1ENSG00000186350.12protein_codingRXRANoNo6256P19793
Q6P3U7
TCGA Plot Options
Drug Information
GeneRXRA
DrugBank IDDB00749
Drug NameEtodolac
Target IDBE0000412
UniProt IDP19793
Regulation Typeother
PubMed IDs15699354
CitationsKolluri SK, Corr M, James SY, Bernasconi M, Lu D, Liu W, Cottam HB, Leoni LM, Carson DA, Zhang XK: The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis. Proc Natl Acad Sci U S A. 2005 Feb 15;102(7):2525-30. Epub 2005 Feb 7.
GroupsApproved; Investigational; Vet_approved
Direct ClassificationIndolyl carboxylic acids and derivatives
SMILESCCC1=C2NC3=C(CCOC3(CC)CC(O)=O)C2=CC=C1
PathwaysEtodolac Action Pathway
PharmGKBPA449550
ChEMBLCHEMBL622